PartsTable
Technical Data Sheet
Download PDF

ANGIOVIST 370 — DIATRIZOATE MEGLUMINE AND DIATRI

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

ANGIOVIST 370: DIATRIZOATE MEGLUMINE AND DIATRI.

DIATRIZOATE MEGLUMINE AND DIATRI. Key specifications include administration: INTRAVASCULAR, special_features: PRESERVATIVE FREE; CONTAINS IODINE 37%, primary_container_type: VIAL, supplementary_features: MEDSEP ITEM FOR DOD,BERLEX LAB, therapeutic_equivalent: BERLEX IMAGING DIV., pharmaceutical_vehicle_type: AQUEOUS. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-215-8103, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
ANGIOVIST 370
NSN: 6505-01-215-8103
NIINs: 012158103, 012307171, 012691903
FSC: 6505 — Drugs and Biologicals
CAGE: 59463 — BAYER HEALTHCARE PHARMACEUTICALS INC DBA BAYER HEALTHCARE PHARMACEUTICALS INC (USA)
SPECIFICATIONS
administrationINTRAVASCULAR
special_featuresPRESERVATIVE FREE; CONTAINS IODINE 37%
primary_container_typeVIAL
supplementary_featuresMEDSEP ITEM FOR DOD,BERLEX LAB
therapeutic_equivalentBERLEX IMAGING DIV.
pharmaceutical_vehicle_typeAQUEOUS
medical_designation_and_gradeUNITED STATES PHARMACOPEIA
total_primary_container_quantity20
primary_container_content_quantity200.000 MILLILITERS
active_medicament_medicinal_strength66.000 PERCENTAGE, W/V DIATRIZOATE MEGLUMINE ACTIVE INGREDIENT AND 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT
part_name_assigned_by_controlling_agencyDIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION USP 200ML 20S
NSN6505-01-215-8103
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available DIATRIZOATE MEGLUMINE AND DIATRI TITLE COMPONENT PN ANGIOVIST 370 MFR DIATRIZOATE MEGLUMINE
KEY FEATURES
•
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
•
MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA
•
PRIMARY CONTAINER TYPE: VIAL
•
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V P-DITOLYMERCURY ACTIVE INGREDIENT AND 66.000 PERCENTAGE, W/V MEGLUMINE ACTIVE INGREDIENT
•
TOTAL PRIMARY CONTAINER QUANTITY: 20
TECHNICAL CHARACTERISTICS
PRIMARY CONTAINER CONTENT QUANTITY100.000 MILLILITERS
MEDICAL DESIGNATION AND GRADEUNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPEVIAL
ACTIVE MEDICAMENT MEDICINAL STRENGTH10.000 PERCENTAGE, W/V P-DITOLYMERCURY ACTIVE INGREDIENT AND 66.000 PERCENTAGE, W/V MEGLUMINE ACTIVE INGREDIENT
TOTAL PRIMARY CONTAINER QUANTITY20
SUBSTITUTES & CROSS-REFERENCES

No substitute or cross-reference records for this part.

LIFECYCLE
NSN statusActive· U.S. Government catalog
Shelf-life managedNo demilitarization required
Ready to buy ANGIOVIST 370?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is ANGIOVIST 370?
ANGIOVIST 370 is a DIATRIZOATE MEGLUMINE AND DIATRI.
What is the NSN for ANGIOVIST 370?
ANGIOVIST 370 is cataloged in the U.S. Government catalog under NSN 6505-01-215-8103. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — ANGIOVIST 370